What if ACT(ACTC) and BioTime(BTX) were to merge? Makes some sense in that BTX's founder and CEO, Dr West, was once ACT's CEO and Chief Scientific Officer, but wait, what would become of Gary? Does anyone really care?
Theres, if we only looked at ACT's finances and structure nobody would buy, it's all speculation, but ACT is getting closer and closer to having a product that cures AMD & SMD diseases.
Also, I'll throw this in; if the 20/400 to 20/40 patient has SMD, and comes from the European trials, then the EMA will orphan drug the cure sometime this Fall, paving the way for the FDA to do the same.